(Q45359804)

13 December 2017

title

The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus (English)

1 reference

13 December 2017

1 reference

vertical transmission

1 reference

1 reference

M Yu

1

1 reference

13 December 2017

Q Jiang

2

1 reference

13 December 2017

Y Ji

3

1 reference

13 December 2017

H Jiang

4

1 reference

13 December 2017

K Wu

5

1 reference

13 December 2017

L Ju

6

1 reference

13 December 2017

X Tang

7

1 reference

13 December 2017

M Wu

8

1 reference

13 December 2017

publication date

1 September 2012

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

13 December 2017

published in

1 reference

13 December 2017

volume

31

1 reference

13 December 2017

issue

9

1 reference

13 December 2017

page(s)

2211-2218

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-012-1557-2

13 December 2017

exact match

0 references

cites work

A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

General Epidemiological Parameters of Viral Hepatitis A, B, C, and E in Six Regions of China: A Cross-Sectional Study in 2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Hepatitis viruses: mother to child transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Efficacy of peripartum antiviral treatment for hepatic failure due to hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Management of hepatitis B: summary of a clinical research workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Hepatitis B viral infection treated with lamivudine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Nationwide vaccination: a success story in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Does hepatitis B virus prenatal transmission result in postnatal immunoprophylaxis failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Interruption of HBV intrauterine transmission: a clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Effect of maternal use of antiretroviral agents on serum insulin levels of the newborn infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Vertical transmission of hepatitis B virus despite maternal lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Successful treatment of fulminant hepatitis B during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Chronic hepatitis B virus infection in Asian countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Hepatitis B treatment: Current best practices, avoiding resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1557-2

Analysis of prognosis-associated factors in fulminant viral hepatitis during pregnancy in China

21 January 2018

1 reference

12 December 2020

Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis

1 reference

12 December 2020

[An investigation on the transmission routes and early diagnosis of intrauterine infection induced by hepatitis B virus]

1 reference

12 December 2020

Management and treatment of pregnant women with hepatitis B

1 reference

12 December 2020

Liver disease in pregnancy

1 reference

12 December 2020

Effects of prenatal exposure to Zidovudine and Lamivudine on brainstem auditory evoked potentials in infants from HIV-infected women.

1 reference

12 December 2020

Hepatitis B surveillance in the Netherlands, 2002-2005: acute infection is mainly via sexual contact while chronic infection is via vertical transmission through mothers from endemic regions

1 reference

12 December 2020

Mother-to-child transmission of hepatitis B virus, in Ouagadougou, Burkina Faso

1 reference

12 December 2020

Hepatitis B and pregnancy

1 reference

12 December 2020

Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection

1 reference

12 December 2020

Management of side effects during antiviral therapy

1 reference

12 December 2020

Prevention of hepatitis B virus vertical transmission: current situation and challenges

1 reference

12 December 2020

Study on the mechanism of intrauterine infection of hepatitis B virus

1 reference

12 December 2020

Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy.

1 reference

12 December 2020

10.1007/S10096-012-1557-2

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1037904294

0 references

1 reference